Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.52 USD | +6.56% | +4.48% | +159.77% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+159.77% | 3.21B | |
+35.82% | 51.51B | |
-6.65% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.40% | 26.13B | |
-15.34% | 19.91B | |
+42.77% | 13.71B | |
+30.59% | 12.38B | |
-3.93% | 11.74B |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- Dyne Therapeutics Says European Medicines Agency Granted Orphan Drug Designation for DYNE-101